Mark W. Frohlich
2015
In 2015, Mark W. Frohlich earned a total compensation of $2.2M as Executive Vice President, Portfolio Strategy at Juno Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $1,604,890 |
| Salary | $400,000 |
| Total | $2,164,890 |
Frohlich received $1.6M in option awards, accounting for 74% of the total pay in 2015.
Frohlich also received $160K in non-equity incentive plan and $400K in salary.
Rankings
In 2015, Mark W. Frohlich's compensation ranked 4,404th out of 13,638 executives tracked by ExecPay. In other words, Frohlich earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,404 out of 13,638 | 68th |
Division Manufacturing | 1,605 out of 5,190 | 69th |
Major group Chemicals And Allied Products | 581 out of 1,854 | 69th |
Industry group Drugs | 460 out of 1,528 | 70th |
Industry Biological Products, Except Diagnostic Substances | 78 out of 254 | 69th |
Source: SEC filing on April 20, 2016.
Frohlich's colleagues
We found four more compensation records of executives who worked with Mark W. Frohlich at Juno Therapeutics in 2015.